The European Commission has cleared the proposed acquisition of joint control of Maxam by Advent and 110 individuals. The individuals include Maxam’s current managers, technical experts, other employees, and co-investors. The U.S.-based Advent is a global financial services company; Maxam is a Spanish company that manufactures explosives, ammuniation, and chemical products.
The acquisition creates vertical links in two areas that the Commission nonetheless found not to raise serious competition concerns:
1) The acquisition creates a vertical link between Advent’s production of the oxo-alcohol 2-ethylhexanol (2-EH) and Maxam’s downstream production of 2-ethyhexyl nitrate (2-EHN), a cetane number improver for diesel fuel. However, there are “alternative suppliers with sufficient production capacity, the increasing trend of imports, a sufficient degree of buyer power from 2-EHN customers and a lack of incentives for the merged entity to engage in an input foreclosure strategy.”
2) There is also a vertical relationship created in the market for tungsten metal powder, boron amorphous, and butyl acetate. The Commission found that the two companies’ market shares and strong competition posed no risk of foreclosure.
Source: EC Press Release
Related content: Reform of the EU Merger Regulation: Looking Out for the Minority (by Christian Riis-Madsen, Sophia Stephanou, & Killian Kehoe (O’Melveny & Myers))
Featured News
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Turkey Hits Meta with $37.20 Million Fine Over Data-Sharing Practices
May 8, 2024 by
CPI
Google Seeks Dismissal of UK Suit Over Alleged Anti-Competitive Practices
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI